BILD 1263

Drug Profile

BILD 1263

Latest Information Update: 24 Sep 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Boehringer Ingelheim (Canada)
  • Class Antivirals
  • Mechanism of Action Ribonucleoside diphosphate reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 18 Sep 2012 Discontinued - Preclinical for Herpes simplex virus infections in Canada (unspecified route)
  • 12 Feb 2001 Profile reviewed but no significant changes made
  • 01 Sep 1998 No-Development-Reported for Herpes simplex virus infections in Canada (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top